Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/06/2003US20030206891 Constructs comprising DNA sequences derived from sequences encoding the proteins FRAP, Tor1, Tor2 and other proteins capable of binding to FKBP:rapamycin
11/06/2003US20030206890 Insect cells utilized that may be transformed with an expression system and thus proteins may be introduced into the composition through direct protein expression by the cells.
11/06/2003US20030206889 Methods of treating anemia using recombinant adeno-associated virus virions
11/06/2003US20030206888 Herpes simplex virus strains
11/06/2003US20030206887 RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
11/06/2003US20030206886 Neutralization of immune suppressive factors for the immunotherapy of cancer
11/06/2003US20030206885 Vaccine immunotherapy for immune suppressed patients
11/06/2003US20030206188 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030206187 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003CA2827114A1 Multi plasmid system for the production of influenza virus
11/06/2003CA2510557A1 Tomato plants that exhibit resistance to botrytis cinerea
11/06/2003CA2484341A1 Novel 35 kd protein
11/06/2003CA2484223A1 Use of human neural stem cells secreting gdnf for treatment of parkinson's and other neurodegenerative diseases
11/06/2003CA2484079A1 Expression systems for stem-loop rna molecule having rnai effect
11/06/2003CA2483980A1 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003CA2483819A1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003CA2483747A1 Cells for detection of influenza and parainfluenza viruses
11/06/2003CA2483701A1 Constitutively active histamine h3 receptor mutants and uses thereof
11/06/2003CA2483564A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003CA2483518A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
11/06/2003CA2483513A1 Reporter-selectable hepatitis c virus replicon
11/06/2003CA2483505A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003CA2483498A1 Generation of plants with improved pathogen resistance
11/06/2003CA2483489A1 Characterization of single stranded nucleic acids by melting analysis of secondary structure using double strand-specific nucleic acid dye
11/06/2003CA2483485A1 Height-related gene
11/06/2003CA2483483A1 Process for preparing oligonucleotides
11/06/2003CA2483468A1 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
11/06/2003CA2483436A1 N-acetylglucosaminyltransferase vb coding sequence, recombinant cells and methods
11/06/2003CA2483431A1 Alternatively spliced nucleic acid molecules
11/06/2003CA2483387A1 Production of cloned offspring from cooled carcasses
11/06/2003CA2483349A1 Amplification of dna to produce single-stranded product of defined sequence and length
11/06/2003CA2483337A1 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003CA2483270A1 Treatment of alpha-galactosidase a deficiency
11/06/2003CA2483150A1 Protein interaction system for multisubunit complexes
11/06/2003CA2483126A1 Polypeptides and biosynthetic pathways for the production of monatin
11/06/2003CA2483106A1 Decoys for treating and/or preventing th2 cytokine-related allergic diseases, gata3 mutant proteins and, pharmaceutical compositions comprising the decoys and the proteins
11/06/2003CA2483007A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003CA2482996A1 Vitamin d3 upregulated protein 1 treats post-infarct myocardial ischemia
11/06/2003CA2482946A1 Multi plasmid system for the production of influenza virus
11/06/2003CA2482930A1 Epha2 antigen t epitopes
11/06/2003CA2482425A1 Constant length signatures for parallel sequencing of polynucleotides
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480314A1 Method of separating poly-3-hydroxyalkanoic acid
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/06/2003CA2463725A1 Compilations of nucleic acids and arrays and methods of using them
11/06/2003CA2448574A1 Novel 33 phage vectors
11/05/2003EP1359422A2 Microarray with structured and unstructured probes
11/05/2003EP1359223A2 Recombinant AAV preparation substantially free of wt aav virus
11/05/2003EP1359222A2 Hybrid human/porcine factor VIII
11/05/2003EP1359221A2 HIV antisense proteins
11/05/2003EP1359220A2 Transgenic plants expressing a cytokine and an autoantigen
11/05/2003EP1359218A1 Rna showing neuron survival activity
11/05/2003EP1359217A1 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues
11/05/2003EP1359160A1 Androgen receptor overexpressing skeletal myoblasts
11/05/2003EP1359158A2 Trp-p8 splice variants and regulatory RNA
11/05/2003EP1359156A2 Papilloma virus vaccine
11/05/2003EP1358616A2 Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the dna
11/05/2003EP1358485A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
11/05/2003EP1358458A2 Mass defect labeling for the determination of oligomer sequences
11/05/2003EP1358356A1 Dna markers for meat tenderness
11/05/2003EP1358354A1 Method for identifying compounds modulating reverse cholesterol transport
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358352A2 Solid support assay systems and methods utilizing non-standard bases
11/05/2003EP1358351A2 Diagnosis of known genetic parameters within the mhc
11/05/2003EP1358350A2 Polynucleotide sequence assay
11/05/2003EP1358349A2 Cancer gene determination and therapeutic screening using signature gene sets
11/05/2003EP1358348A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/05/2003EP1358347A2 Genes expressed in foam cell differentiation
11/05/2003EP1358346A2 Real time quantitative pcr with intercalating dye for single and multiplex target dna
11/05/2003EP1358345A1 Multitemperature single strand conformation polymorphism (msscp)
11/05/2003EP1358342A2 Retroviral vectors for transduction into quiescent cells and packaging systems for them
11/05/2003EP1358341A2 Methods for generating resistance against cgmmv in plants
11/05/2003EP1358340A1 Control of bacterial infection by quenching quorum-sensing of plant pathogenic bacteria
11/05/2003EP1358339A2 56939, a human acyl-coa thioesterase family member and uses thereof
11/05/2003EP1358338A2 Human protein kinase n-like polypeptide and uses thereof
11/05/2003EP1358337A1 Nucleotide sequences which code for the otsa gene of c. glutamicum
11/05/2003EP1358336A2 Human serine-threonine kinase
11/05/2003EP1358335A2 Nucleotide sequence mediating male fertility and method of using same
11/05/2003EP1358334A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
11/05/2003EP1358333A2 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358331A2 Clostridium difficile vaccine
11/05/2003EP1358330A2 Transporters and ion channels
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358327A2 Proteins and nucleic acids encoding same
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358324A2 33217, a human amp-binding enzyme family member and uses thereof
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358322A2 A method of increasing complementarity in a heteroduplex polynucleotide
11/05/2003EP1358321A1 Insertional mutagenesis technique
11/05/2003EP1358320A2 68730 and 69112 protein kinase molecules and uses therefor
11/05/2003EP1358318A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies
11/05/2003EP1358317A1 Activation of nuclear transfer embryos
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1358208A2 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/05/2003EP1358207A1 Sol-fusin: use of gp64-6his to catalyze membrane fusion
11/05/2003EP1358203A2 Methods and compositions for use in spliceosome mediated rna trans-splicing
11/05/2003EP1358199A2 Antisense modulation of src-1 expression
1 ... 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 ... 4023